Suchergebnisse - "Emadi, Ashkan"

PubPharm (90)

1

Clinical outcomes of patients with acute myeloid leukemia and cardiovascular disease

enthalten in: Leukemia research | 2024

von Sanchez-Petitto, G. | Goloubeva, O. | Masur, J. | +13

2

Community-engaged basic science in an NCI-designated comprehensive cancer center : antioxidants and chemotherapeutic efficacy

enthalten in: Cancer causes & control : CCC | 2024

von Bollino, D. | Woodard, N. | Tighe, K. | +5

3

Aspacytarabine for the treatment of patients with AML unfit for intensive chemotherapy : a phase 2 study

enthalten in: Blood advances | 2023

von Altman, J. | Zuckerman, T. | Koprivnikar, J. | +23

4

Cytogenetics and molecular genetics of myelodysplastic neoplasms

enthalten in: Best practice & research. Clinical haematology | 2023

von Ning, Y. | Zhang, Y. | Kallen, M. | +2

5

Olanzapine within steroid-sparing antiemetic regimen to prevent chemotherapy-induced nausea and vomiting in patients with acute leukemia receiving multi-day intensive chemotherapy

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2023

von Hsu, G. | Bernhardi, C. | Lawson, J. | +4

6

Impact of pegaspargase dose capping on incidence of pegaspargase-related adverse events in adults

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2023

von Tiao, E. | Bernhardi, C. | Trovato, J. | +4

7

Mesothelioma cancer cells are glutamine addicted and glutamine restriction reduces YAP1 signaling to attenuate tumor formation

enthalten in: Molecular carcinogenesis | 2023

von Adhikary, G. | Shrestha, S. | Naselsky, W. | +6

8

Hypertension, smoking, and preexistence of multiple cardiac risk factors correlate with carfilzomib-induced cardiovascular adverse events in a racially diverse population

enthalten in: Frontiers in cardiovascular medicine | 2023

von Doran, S. | Mysore, M. | Kassaian, S. | +5

9

Safety, Outcomes, and T-Cell Characteristics in Patients with Relapsed or Refractory MDS or CMML Treated with Atezolizumab in Combination with Guadecitabine

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von O'Connell, C. | Baer, M. | Ørskov, A. | +20

10

Arsenic trioxide dose capping to decrease toxicity in the treatment of acute promyelocytic leukemia

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2022

von Zacholski, K. | Hambley, B. | Hickey, E. | +13

1
2
3
4
5
6
7
8
9
Nächster »
[9]